SECAUCUS, N.J., Aug. 15, 2025 /PRNewswire/ — Quest Diagnostics Incorporated (NYSE: DGX), a heavyweight in the diagnostic information services arena, has announced that its Chairman, CEO, and President, Jim Davis, is slated to address the Baird 2025 Global Healthcare Conference in New York City. Davis will delve into the company’s strategic roadmap, recent performance metrics, and offer insights into the evolving dynamics and emerging trends shaping the healthcare market. The presentation is scheduled for Wednesday, September 10, 2025, at 10:50 a.m. Eastern Time.
For investors and industry watchers keen to glean Davis’s perspective, the fireside chat and subsequent Q&A session will be broadcast live via webcast on Quest Diagnostics’ investor relations website: ir.QuestDiagnostics.com. A replay of the webcast will be archived within 24 hours of the live event and will be accessible until October 3, 2025, offering a chance to catch up on key takeaways for those who miss the live broadcast.
About Quest Diagnostics
Quest Diagnostics positions itself as a vital player in the healthcare ecosystem, aiming to foster a healthier world through diagnostic insights. By leveraging its expansive laboratory testing capabilities, the company empowers individuals, physicians, and organizations to make informed decisions aimed at improving health outcomes. Drawing from a vast, anonymized database of clinical lab results, Quest aims to uncover innovative approaches to disease identification and treatment, promote healthy behaviors, and enhance healthcare management practices. Serving approximately one in three adult Americans and half of the physicians and hospitals in the United States annually, Quest Diagnostics, with its workforce of over 55,000, emphasizes the transformative potential of diagnostic insights in driving positive change. www.QuestDiagnostics.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-baird-2025-global-healthcare-conference-302531411.html
SOURCE Quest Diagnostics
Original article, Author: Jam. If you wish to reprint this article, please indicate the source:https://aicnbc.com/7293.html